Adjuvant therapy for resectable colorectal carcinoma with 5-fluorouracil portal vein infusion.
Cremona
F
F
Division of Surgical Oncology C, National Cancer Institute of Naples, Italy.
Izzo
F
F
Ruffolo
F
F
Palaia
R
R
Parisi
V
V
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D011169:Portal Vein; D011184:Postoperative Period; D012189:Retrospective Studies; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil